SICMAFARMA

ACTIVE SUBSTANCE CONCENTRATION: 5 mg/mL PHARMACEUTICAL FORM: Solution for injection. ROUTE OF ADMINISTRATION: MI – Intramuscular / IV – Intravenous PRODUCT PRESENTATION: Box x 5 ampoules of type I glass x 3 mL. VALIDITY TIME: 2 years from manufacture. LABORATORY MANUFACTURER: Farbe Firma Pvt LTD. COUNTRY OF ORIGIN: India. EXPORTER: SRS Life Sciences Pte Ltd. STORAGE: Store at a temperature not exceeding 30°C in the original container and packaging. ATC: N05CD08. INDICATIONS AND / OR THERAPEUTIC USE: Sedative, hypnotic. Disorders in the rhythm of sleep and all forms of insomnia, sedation in premediation before interventions or diagnostic procedures. CONTRAINDICATIONS: Contraindicated in patients with known hypersensitivity to benzodiazepines, acute pulmonary failure, severe chronic obstructive pulmonary disease, and acute narrow-angle glaucoma. Administer slowly in elderly or debilitated patients. It has been linked to respiratory arrest.<br />
<br />
*AUTHORIZED PURCHASE FOR PROFESSIONAL USE ONLY - SUBJECTED TO EACH COUNTRY'S REGULAMENTS